Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Expert Opin Drug Deliv. 2009 Aug;6(8):771–784. doi: 10.1517/17425240903081705

Table 3.

Problems with current anti-HIV therapy.

Problems associated with anti-HIV drug therapy
Poor absorption and limited bioavailability
Polypharmacy
Requirement of high dose and chronic therapy
Lack of compliance
Drug resistance
High plasma protein binding
Substrate for efflux transporters
Limited penetration across the BBB